Gut Repair & Microbiome Restoration
BPC-157 and KPV identity for GI-adjacent research. Mouse and gastric-cytoprotection papers are not a leaky-gut, IBS, Crohn’s, or UC protocol.
Duration
4-8 weeks
First reports
1-2 weeks
SKUs on this map
2
1Overview
BPC-157 and KPV have a large animal GI file. Human IBD, IBS, and "leaky gut" trials are not here. This page maps identity and dosing math. It is not a Crohn’s, UC, or zonulin protocol.
Ideal Candidates
Contraindications
2The Science
BPC-157 is a gastric pentadecapeptide with extensive rat ulcer, fistula, and anastomosis papers (Sikiric). KPV is an α-MSH fragment with murine colitis models. Complementary marketing is not a combination RCT and not a substitute for gastroenterology care.
3Clinical Evidence
Key Findings
BPC-157 accelerates healing of gastric ulcers, fistulas, and colonic anastomoses in multiple rat models
Sikiric et al., extensive publication seriesDOI ↗
BPC-157 promotes angiogenesis and modulates the NO system in digestive tract healing
Preclinical pharmacology
KPV inhibits NF-kB activation and reduces colitis severity in DSS and TNBS murine models
Dalmasso et al., PLoS ONE
KPV is transported into intestinal epithelial cells via PepT1, which is upregulated in inflamed colon tissue
Preclinical transport studies
Oral BPC-157 (stable Arginine salt form) survives gastric acid and retains bioactivity in GI tract
Sikiric lab, rat models
Study Limitations
- ⚠Neither BPC-157 nor KPV is FDA-approved for any indication
- ⚠Virtually all evidence comes from animal models and cell culture; human clinical trials are severely lacking
- ⚠Oral bioavailability of BPC-157 depends heavily on formulation (Arginine salt vs. acetate)
- ⚠KPV dosing in humans is entirely extrapolated from preclinical data - no established human therapeutic doses
- ⚠Long-term safety data in humans does not exist for either compound
4The Peptide Stack
BPC-157
View Profile →Accelerates the healing of the intestinal endothelium by promoting angiogenesis (new blood vessel formation) and heavily modulating the nitric oxide system in the digestive tract.
Alpha-MSH-derived tripeptide that inhibits NF-kB signaling - the master regulator of inflammatory responses. Transported into intestinal cells via PepT1 (which is upregulated during gut inflammation, creating preferential accumulation at sites of damage).
Mechanism: Inhibits NF-kB nuclear translocation, reducing TNF-alpha, IL-6, and IL-1beta production. PepT1-mediated uptake ensures highest concentrations precisely where inflammation is most active.
5Protocol Tiers
Targeted Epithelial Repair
Using oral administration to ensure the peptides make direct contact with the inflamed intestinal lining.
6Lifestyle Integration
Lifestyle notes that travel with these SKUs. Not a prescription and not required for the math to be valid.
Training
Avoid ultra-endurance training which causes ischemic damage (blood diversion from the gut) during the early healing phase.
Nutrition
Implement a strict elimination diet (temporarily remove gluten, dairy, refined sugar). The peptides cannot out-heal a continuously inflammatory diet. Incorporate high-quality bone broths and L-glutamine.
Sleep
Gut repair strictly occurs during rest. Insufficient sleep exacerbates intestinal permeability.
Stress Management
The gut-brain axis is immediate. Psychological stress instantly alters gut motility and decreases protective mucus production. Stress management is fundamental to gut healing.
7Timeline & Expectations
Days 1-7
Weeks 2-6
8Monitoring & Safety
Key Metrics to Track
Troubleshooting
Symptoms unchanged after 3 weeks
- Ongoing consumption of an unrecognized trigger food
- Using degraded/low quality oral BPC-157 that breaks down in stomach acid (needs the Arginine salt base)
- Stricten the elimination diet carefully. Switch to a verified Arg-BPC-157 oral source or try subcutaneous injection.
9Further Reading
Dive deeper into the individual peptides and methodologies behind this protocol.
BPC-157 and KPV: gut marketing vs the animal file
BPC-157 and KPV target gut inflammation and mucosal repair through complementary mechanisms. This guide covers their combined protocol, evidence, and dosing for IBS, IBD, and leaky gut.
Read article →BPC-157 Dosage Guide: How Much to Take and How to Calculate
Complete BPC-157 dosing guide with reconstitution examples, syringe unit calculations, and stacking protocols with TB-500.
Read article →BPC-157 vs TB-500: Recovery Peptide Comparison, Stacking Guide & Dosing
Head-to-head comparison of BPC-157 and TB-500 - mechanisms, half-life, dosing protocols, clinical evidence, stacking strategies, and which to choose for injury recovery.
Read article →BPC-157 Oral vs Injectable: Does Oral BPC-157 Actually Work?
Can BPC-157 survive stomach acid? The science behind oral vs injectable BPC-157 - bioavailability data, when oral makes sense, and when you need subcutaneous injection.
Read article →